Neuroscience Research / Medco Research Institute

Research Areas

Current Research Studies

Pharmacogenetic-Directed Prescribing of Psychotropic Medications (PREDICT PSYMEDS)

Relative Effectiveness of Schizophrenia Therapy (REST)

Archived Research Studies

America's State of Mind: New Report Finds Americans Increasingly Turn to Medications to Ease their Mental Woes; Women Lead the Trend

Does Adherence to Antidepressants Impact Healthcare Costs Among Patients with Mood Disorders?

Rate of Non-Adherence Prior to Upward Dose Titration in Previously Stable Antidepressant Users

Adherence as a Predictor of the Utilization of Healthcare Resources in a Multiple Sclerosis Population Using Interferons

Relationship Between Adherence to Interferons to Treat Multiple Sclerosis and the Number and Severity of Relapses

Exploring the Impact of Dispensing Channel on Medication Adherence Among Multiple Sclerosis Patients

Author Perspectives

Bryan Dechairo, PhD

Senior Director, Extramural R&D Head
Medco Research Institute

Dr. Bryan Dechairo joined Medco in January 2009 as the head of Extramural Research and Development for the Medco Research Institute. In this role, Dr Dechairo translates clinically valid tools into widely accessible and effective medical and pharmacy practice innovations that improve health outcomes for Medco members and decrease the cost of healthcare for Medco clients. Additionally, Dr Dechairo is responsible for business development and strategic alliances which impact Medco’s healthcare innovation pipeline from research through commercial.

Research Areas

Popular Topics

Current Research Studies

Archived Research Studies

Author Perspectives

Bryan Dechairo, PhD